EGFR and non-small cell lung carcinoma: Among EGFR activating mutations, 19del and L858R were found in 45–55% east Asian patients with NSCLC, while rare EGFR mutations including S768I, L861Q, G719X, etc. have the prevalence of 1.1–2.4%, respectively (10).